Both in Diagnostics
QuidelOrtho vs Myriad Genetics
Over the past year QDEL returned −47.1% and MYGN returned −6.8%; their daily moves had a correlation of 0.23.
QDEL −47.1% MYGN −6.8%Growth of $1, one year, split-adjusted
| Metric | QDEL | MYGN |
|---|---|---|
| Price | $14.35 | $6.02 |
| Market cap | $984.1M | $575.8M |
| Today | +1.85% | −0.33% |
| 1 month | +14.2% | +40.7% |
| 6 months | +30.9% | +46.5% |
| Year to date | −49.8% | −2.1% |
| 1 year | −48.2% | −26.4% |
| Revenue growth (YoY) | +2.8% | −10.5% |
| Gross margin | 43.3% | 66.6% |
| Net margin | −14.7% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 0.7× |
| Net cash | -$2.77B | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 85.0% |
| Short % of float | 19.2% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).